Utrecht’s Guideways raises pre-seed funding to help medtech startups cut regulatory delays with AI

Dutch AI company Guideways, helping medtech businesses navigate regulatory and compliance, has raised pre-seed financing.

Contentlockr

Utrecht-based Guideways, an AI company helping medtech businesses navigate regulatory and compliance complexity, has raised pre-seed financing from Healthy.Capital and Rising Star Venture Partners.

Healthy.Capital is an early-stage investment fund focused on healthcare startups with a vision of transforming healthcare through technology.

Douwe Jippes, Co-founder and Managing Partner at Healthy.Capital, says, “The team at Guideways has a deep, personal understanding of the problem they are solving. They help companies to bring innovations to market faster and more successfully by significantly reducing the approval time and costs, fundamentally changing how medical devices are brought to market. This makes healthcare innovation more accessible and efficient, which perfectly aligns with our mission at Healthy.Capital to make healthcare affordable and accessible.”

Fund utilisation

The company will utilise the funds to launch and scale its agentic AI platform, designed to assist medical device companies in achieving regulatory approval and delivering lifesaving technologies to patients years faster.

Additionally, the funding will also support the commercial launch activities, ongoing platform development, and expansion toward European MDR and reimbursement frameworks in 2026.

Guideways: Focused on FDA approval of medical devices

Founded by Sander Denissen and Alexander Habermeier, Guideways.ai is an AI company that helps medtech businesses navigate regulatory complexity.

Annually, tens of thousands of promising medical technologies are slowed down by the complexity of regulation, quality and reimbursement.

These processes today consume up to 75 per cent of medtech development costs and can delay market entry by 31 to 66 months.

The Dutch company has developed AI agents that cut through regulatory approval, compliance, and reimbursement complexity for medtech innovators.

The company’s platform automates the most time-consuming parts of compliance through a suite of specialised AI agents, focused initially on the US FDA approval process:

FDA Sherpa: Guides teams from a concept description to a detailed approval strategy, identifying the correct classification, pathway, requirements, and standards.FDA Reviewer: Performs in-depth checks of regulatory submissions, reviewing hundreds of documents for compliance and suggesting fixes.FDA Researcher: Enables natural-language exploration of a knowledge base of more than 150,000 reference documents, combining information intelligently to answer complex queries.

Benjamin Sieters, Investment Director at Rising Star Venture Partners, says, “Guideways is a prime example of a company with the potential for fast and massive impact. By addressing barriers within the innovation pipeline, the company empowers health technology innovators to succeed and bring their solutions faster and more cost-effectively to a global market.” 

We have seen first-hand how Guideways’ platform can reliably fast-track complicated and expensive steps in the critical route to regulatory approval, compliance and reimbursement. We are proud to back their mission to accelerate the availability of groundbreaking medical technologies,” concludes Sieters.